Our findings highlight a novel gene-environment interaction pattern between LRRK2 risk variants and E. coli in pathological α-syn initiation and the pathogenesis of LRRK2-associated sPD, providing new targets for interfering with the onset and progression of the disease. This evidence concerns the gene LRRK2 and Platelet storage pool disease.